Market Indices


Latest News

from Northland Securities issued a price target of $18.50 for...

June 26, 2026   BNED 2.31%

David Smith from Truist Financial issued a price target of $160.00...

June 26, 2026   BNY -1.29%

from Raymond James issued a price target of $20.00 for...

June 26, 2026   ACHV 5.61%

from Lake Street issued a price target of $15.00 for...

June 26, 2026   AOUT 17.05%

from Roth Capital issued a price target of $13.50 for...

June 26, 2026   AOUT 17.05%


Price Targets

from Northland Securities issued a price target of $18.50 for BNED on 2026-06-26 13:18:10.The adjusted price target was set to $18.50.At the time of the announcement, BNED...

June 26, 2026   BNED 2.31%

David Smith from Truist Financial issued a price target of $160.00 for BNY on 2026-06-26 12:59:58.The adjusted price target was set to $160.00.At the time of the announcement,

June 26, 2026   BNY -1.29%

from Raymond James issued a price target of $20.00 for ACHV on 2026-06-26 12:11:21.The adjusted price target was set to $20.00.At the time of the announcement, ACHV...

June 26, 2026   ACHV 5.61%

from Lake Street issued a price target of $15.00 for AOUT on 2026-06-26 11:58:49.The adjusted price target was set to $15.00.At the time of the announcement, AOUT...

June 26, 2026   AOUT 17.05%

from Roth Capital issued a price target of $13.50 for AOUT on 2026-06-26 11:54:49.The adjusted price target was set to $13.50.At the time of the announcement, AOUT...

June 26, 2026   AOUT 17.05%



Market Movers

Top Gainers (%)
EGRX
Eagle Pharmaceuticals, In
0.67
538.10%
LTCH
Latch, Inc.
0.18
80.00%
CRIS
Curis, Inc.
0.32
54.62%
ARL
American Realty Investors
21.50
34.12%
DAVEW
Dave Inc.
1.95
25.96%
ZTEK
Zentek Ltd.
0.49
25.56%
SGMO
Sangamo Therapeutics, Inc
0.05
25.00%
PYXS
Pyxis Oncology, Inc.
2.77
24.22%

Annual/Quarterly Reports Summary

In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...

November 6, 2024   AIP -0.69%

In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...

November 6, 2024   EOSEW -34.96%

In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...

November 6, 2024   EOSE -2.63%

In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...

November 5, 2024   STOK 5.26%

In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...

November 5, 2024   BSVN 4.71%